Literature DB >> 19826117

Qualitative age interactions in breast cancer studies: mind the gap.

William F Anderson1, Ismail Jatoi, Mark E Sherman.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19826117      PMCID: PMC2773215          DOI: 10.1200/JCO.2009.22.9450

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  42 in total

1.  Carcinoma of the breast; results from statistical research.

Authors:  J CLEMMESEN
Journal:  Br J Radiol       Date:  1948-12       Impact factor: 3.039

Review 2.  Threats to applicability of randomised trials: exclusions and selective participation.

Authors:  A Britton; M McKee; N Black; K McPherson; C Sanderson; C Bain
Journal:  J Health Serv Res Policy       Date:  1999-04

3.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

4.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; Jared N Schwartz; Karen L Hagerty; D Craig Allred; Richard J Cote; Mitchell Dowsett; Patrick L Fitzgibbons; Wedad M Hanna; Amy Langer; Lisa M McShane; Soonmyung Paik; Mark D Pegram; Edith A Perez; Michael F Press; Anthony Rhodes; Catharine Sturgeon; Sheila E Taube; Raymond Tubbs; Gail H Vance; Marc van de Vijver; Thomas M Wheeler; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2006-12-11       Impact factor: 44.544

5.  Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.

Authors:  N Wolmark; J Wang; E Mamounas; J Bryant; B Fisher
Journal:  J Natl Cancer Inst Monogr       Date:  2001

6.  Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer.

Authors:  A J Nixon; D Neuberg; D F Hayes; R Gelman; J L Connolly; S Schnitt; A Abner; A Recht; F Vicini; J R Harris
Journal:  J Clin Oncol       Date:  1994-05       Impact factor: 44.544

7.  Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.

Authors:  Carey K Anders; David S Hsu; Gloria Broadwater; Chaitanya R Acharya; John A Foekens; Yi Zhang; Yixin Wang; P Kelly Marcom; Jeffrey R Marks; Phillip G Febbo; Joseph R Nevins; Anil Potti; Kimberly L Blackwell
Journal:  J Clin Oncol       Date:  2008-07-10       Impact factor: 44.544

8.  'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer.

Authors:  M C Pike; M D Krailo; B E Henderson; J T Casagrande; D G Hoel
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

9.  Age-related crossover in breast cancer incidence rates between black and white ethnic groups.

Authors:  William F Anderson; Philip S Rosenberg; Idan Menashe; Aya Mitani; Ruth M Pfeiffer
Journal:  J Natl Cancer Inst       Date:  2008-12-09       Impact factor: 13.506

10.  Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.

Authors:  Christina Yau; Vita Fedele; Ritu Roydasgupta; Jane Fridlyand; Alan Hubbard; Joe W Gray; Karen Chew; Shanaz H Dairkee; Dan H Moore; Francesco Schittulli; Stefania Tommasi; Angelo Paradiso; Donna G Albertson; Christopher C Benz
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more
  20 in total

1.  Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients.

Authors:  Esther M de Kruijf; Esther Bastiaannet; Francesca Rubertá; Anton J M de Craen; Peter J K Kuppen; Vincent T H B M Smit; Cornelis J H van de Velde; Gerrit Jan Liefers
Journal:  Mol Oncol       Date:  2014-04-08       Impact factor: 6.603

2.  Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications.

Authors:  Maeve Mullooly; Ruth M Pfeiffer; Sarah J Nyante; Brandy M Heckman-Stoddard; Marjorie Perloff; Ismail Jatoi; Louise A Brinton; Erin J Aiello Bowles; Robert N Hoover; Andrew Glass; Amy Berrington de Gonzalez; Mark E Sherman; Gretchen L Gierach
Journal:  J Clin Oncol       Date:  2016-03-28       Impact factor: 44.544

Review 3.  How many etiological subtypes of breast cancer: two, three, four, or more?

Authors:  William F Anderson; Philip S Rosenberg; Aleix Prat; Charles M Perou; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2014-08-12       Impact factor: 13.506

4.  Epidemiology of triple negative breast cancers.

Authors:  Gretchen L Gierach; Aileen Burke; William F Anderson
Journal:  Breast Dis       Date:  2010

5.  Declining incidence of contralateral breast cancer in the United States from 1975 to 2006.

Authors:  Hazel B Nichols; Amy Berrington de González; James V Lacey; Philip S Rosenberg; William F Anderson
Journal:  J Clin Oncol       Date:  2011-03-14       Impact factor: 44.544

6.  Breast cancers in U.S. residing Indian-Pakistani versus non-Hispanic White women: comparative analysis of clinical-pathologic features, treatment, and survival.

Authors:  Meena S Moran; Lou Gonsalves; Donna M Goss; Shuangge Ma
Journal:  Breast Cancer Res Treat       Date:  2011-02-08       Impact factor: 4.872

7.  Divergent estrogen receptor-positive and -negative breast cancer trends and etiologic heterogeneity in Denmark.

Authors:  William F Anderson; Philip S Rosenberg; Lucia Petito; Hormuzd A Katki; Bent Ejlertsen; Marianne Ewertz; Birgitte B Rasmussen; Maj-Britt Jensen; Niels Kroman
Journal:  Int J Cancer       Date:  2013-06-13       Impact factor: 7.396

8.  Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.

Authors:  Jonine D Figueroa; Kathleen C Flanders; Montserrat Garcia-Closas; William F Anderson; Xiaohong R Yang; Rayna K Matsuno; Máire A Duggan; Ruth M Pfeiffer; Akira Ooshima; Robert Cornelison; Gretchen L Gierach; Louise A Brinton; Jolanta Lissowska; Beata Peplonska; Lalage M Wakefield; Mark E Sherman
Journal:  Breast Cancer Res Treat       Date:  2009-11-24       Impact factor: 4.872

9.  The clinical prognostic value of molecular intrinsic tumor subtypes in older breast cancer patients: A FOCUS study analysis.

Authors:  Charla C Engels; Mandy Kiderlen; Esther Bastiaannet; Antien L Mooyaart; Ronald van Vlierberghe; Vincent T H B M Smit; Peter J K Kuppen; Cornelis J H van de Velde; G J Liefers
Journal:  Mol Oncol       Date:  2015-11-24       Impact factor: 6.603

10.  The effect of local therapy on breast cancer mortality: is there an age-interaction?

Authors:  Ismail Jatoi
Journal:  Indian J Surg Oncol       Date:  2013-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.